Spots Global Cancer Trial Database for hepatobiliary cancer
Every month we try and update this database with for hepatobiliary cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program | NCT03475966 | Pancreatic Canc... Liver Cancer Bile Duct Cance... Hepatobiliary C... Surgery | Exercise Nutrition Relaxation tech... | 18 Years - 95 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR) | NCT06328101 | Autoimmune Panc... Autoimmune Panc... | 18 Years - | University Medical Center Goettingen | ||
Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR) | NCT06328101 | Autoimmune Panc... Autoimmune Panc... | 18 Years - | University Medical Center Goettingen | ||
Targeted Navigation in Hepatocellular Carcinoma (HCC) | NCT06260943 | Hepatocellular ... Cholangiocarcin... Hepatobiliary C... | Target Navigati... | 18 Years - | University of Miami | |
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) | NCT04498767 | Gynecologic Can... Skin Cancer Head and Neck C... Sarcoma Renal Cancer Bladder Cancer Upper Urinary T... Pancreatic Canc... Hepatobiliary C... Gastric Cancer Small Bowel Can... Esophageal Canc... Melanoma Colon Cancer Oligometastasis | Stereotactic bo... Palliative RT | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors | NCT03895970 | Liver Neoplasm ... Cholangiocarcin... Combinational I... Biomarker | Lenvatinib plus... | 18 Years - | Peking Union Medical College Hospital | |
Exercise Preconditioning With Cancer Surgeries | NCT04923672 | Colorectal Canc... Hepatobiliary C... Gynecologic Can... | Moderate contin... High intensity ... | 18 Years - | University of Virginia | |
Targeted Navigation in Hepatocellular Carcinoma (HCC) | NCT06260943 | Hepatocellular ... Cholangiocarcin... Hepatobiliary C... | Target Navigati... | 18 Years - | University of Miami | |
Senior Adult Hepatobiliary Prehab Study | NCT05921552 | Hepatobiliary C... Cholangiocarcin... Liver Metastase... | Resistance Trai... Aerobic Trainin... | 65 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Observational Study Protocol: LIVER-R | NCT06252753 | Hepatobiliary C... | Durvalumab-base... Durvalumab-base... | 18 Years - 130 Years | AstraZeneca | |
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | NCT02810652 | Pancreatic Canc... Esophageal Canc... Gastric Cancer Rectal Cancer Hepatobiliary C... Colon Cancer | Usual Care Perioperative G... | 65 Years - | Massachusetts General Hospital | |
Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR) | NCT06328101 | Autoimmune Panc... Autoimmune Panc... | 18 Years - | University Medical Center Goettingen | ||
NCI SBIR Contract for Patient Navigation Tool Prototype Development | NCT04892927 | Pancreas Cancer Hepatobiliary C... Patient Engagem... | 18 Years - | GMG Arcdata LLC | ||
Targeted Navigation in Hepatocellular Carcinoma (HCC) | NCT06260943 | Hepatocellular ... Cholangiocarcin... Hepatobiliary C... | Target Navigati... | 18 Years - | University of Miami | |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers | NCT05497531 | Hepatobiliary C... Pancreatic Canc... Hepatocellular ... Cholangiocarcin... Ampullary Cance... Pancreatic Carc... | ctDNA Blood Col... | 18 Years - | University of California, Irvine | |
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer | NCT05775159 | Hepatocellular ... Biliary Tract C... | Volrustomig Bevacizumab Lenvatinib Rilvegostomig Gemcitabine Cisplatin | 18 Years - | AstraZeneca | |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease | NCT05366881 | Brain Cancer Breast Cancer Bladder Cancer Cervical Cancer Colorectal Canc... Endometrial Can... Esophageal Canc... Stomach Cancer Head and Neck C... Hepatobiliary C... Leukemia Lung Cancer Lymphoma Multiple Myelom... Ovarian Cancer Pancreatic Canc... Prostate Cancer Renal Cancer Sarcoma Thyroid Cancer | 40 Years - | Adela, Inc |